Programme
Monday 19 May

08:00 to 08:45
Optimising Surgical Management of gBRCAm breast cancer patients
Professor Cliona Kirwan, Professor Michael Gnant

09:00 to 09:05
Welcome
Miss Leena Chagla

09:05 to 09:35
The future of breast cancer treatment
Professor Michael Gnant

09:40 to 09:55
Mastectomy planes and pedicles
Dr Nicola Rocco

09:55 to 10:10
Flat mastectomies
Miss Jenna Morgan

10:10 to 10:25
When mastectomies go wrong
Ms Anushka Chaudhry

10:25 to 10:40
The contralateral breast
Miss Rachel O'Connell

10:40 to 10:55
Q&A panel discussion with speakers
All Faculty

09:40 to 10:00
Pain in the post-treatment breast cancer patient
Dr Sue Hartup

10:00 to 10:20
Anxiety in the post-treatment breast cancer patient
Professor Nazanin Derakhshan

10:20 to 10:40
Restricted mobility after breast cancer treatment
Mrs Karen Livingstone

10:40 to 10:55
Q&A panel discussion with speakers
All Faculty

09:40 to 09:50
Clinicopathological characteristics and technical outcomes of node marking techniques and targeted axillary dissection in patients with node-positive breast cancer undergoing neoadjuvant chemotherapy: Results from 772 participants in ATNEC phase III trial
Miss Monika Kaushik

09:50 to 10:00
The impact of pre-operative Oncotype DX Breast Recurrence Score® testing; the results of the PRE-DX randomised controlled trial
Mr Henry Cain

10:00 to 10:10
Breast augmentation: The ugly truth of the hidden NHS burden
Ms Sadia Jaskani

10:10 to 10:20
Meta-analysis of the long-term oncological safety of immediate breast reconstruction in patients with locally advanced breast cancer
Mr Max Seabrook

10:20 to 10:30
The impact of high penetrance genetic testing on surgical decision making
Ms Akriti Nanda

10:30 to 10:40
Impact of feedback from wearable devices in recovery after breast cancer surgery
Mr Ahmed Latif

10:40 to 10:50
Superior survival and lower recurrence outcomes with breast-conserving surgery compared to mastectomy following neoadjuvant therapy in 607 breast cancer patients
Dr Damiano Gentile

11:35 to 11:50
AR in breast surgery
Professor Pedro Gouveia

11:50 to 12:05
Are we ready for robotic mastectomy?
Dr Antonio Toesca

12:05 to 12:20
AI in breast pathology reporting - A North Wales experience
Dr Anu Gunavardhan

12:20 to 12:35
CINDERELLA Project: The patient side
Professor María João Cardoso

12:35 to 12:50
Q&A panel discussion with speakers
All Faculty

11:35 to 11:45
Submitted paper: A national review of the East Midlands breast pain pathway - community breast pain clinics
Professor John Robertson

11:45 to 12:00
Breast infections
Mr Daniel Leff

12:00 to 12:15
The ENIGMA of Idiopathic Granulomatous Mastitis
Dr Goonj Johri

12:15 to 12:30
Skin conditions of the breast
Dr Jenny Hughes

12:30 to 12:40
ASPIRE
Ms Jennifer Hu

12:40 to 12:50
Q&A panel discussion with speakers
All Faculty

11:35 to 11:45
Submitted paper: Ductal carcinoma In Situ Cavity shave (DISC) Randomised Control Trial - A pilot study protocol
Miss Buket Ertansel

11:45 to 12:05
Decoding DCIS
Professor Elinor Sawyer

12:05 to 12:20
Margins and DCIS
Miss Sarah Tang

12:20 to 12:40
Axillary staging for DCIS
Dr Andreas Karakatsanis

12:25 to 12:55
Q&A panel discussion with speakers
All Faculty

13:00 to 14:00
Neoadjuvant Treatment in Focus: Evaluating Patient Selection and Clinical Outcomes in Early-Stage Triple Negative Breast Cancer
Professor Stuart McIntosh, Miss Sisse Olsen, Dr Elisavet Papadimitraki

14:10 to 14:25
Management of patients undergoing explantation: When and how
Miss Rieka Taghizadeh

14:25 to 14:40
Augmentation revision
Mr Paul Harris

14:40 to 14:55
Breast cancer in augmented breasts
Mr Benjamin Baker

14:55 to 15:10
Update of ALCL/BII
Dr Nicola Rocco

15:10 to 15:25
Q&A panel discussion with speakers
All Faculty

14:10 to 14:20
Submitted paper: Surviving longer, living harder - Addressing inequities in secondary breast cancer care
Mrs Caroline Tweedie

14:20 to 14:35
Metastatic breast cancer: Is there a role for surgery? From a surgical perspective
Professor Bahadir M. Gulluoglu

14:35 to 14:50
Metastatic breast cancer: Is there a role for surgery? From an oncology perspective
Dr Fharat Raja

14:50 to 15:05
Oligometastatic disease: Should we aim for a cure?
Dr Anna Kirby

15:05 to 15:15
Patient view: Independent Cancer Patients’ Voice
Ms Lesley Stephen

15:15 to 15:25
Q&A panel discussion with speakers
All Faculty

14:10 to 14:25
St Gallen Consensus 2025 update
Professor Michael Gnant

14:25 to 14:40
New axillary guidelines
Professor John Benson

14:40 to 14:55
PRECEDENT
Professor Stuart McIntosh

14:55 to 15:10
EndoNET
Professor Ramsey Cutress

15:10 to 15:25
Localisation study updates
Mr Edward St John, Mr Rajiv Dave

15:55 to 16:05
Submitted paper: Does contralateral symmetrising reduction improve wellbeing and satisfaction for patients undergoing oncoplastic breast reduction? A 15-year retrospective cross-sectional study
Dr Raabia Farooqi

16:05 to 16:20
Failed Therapeutic Mammoplasty: Picking up the pieces
Professor Pankaj Roy

16:20 to 16:40
Oncoplastic breast surgery: The uncomfortable truth
Professor María João Cardoso

16:40 to 16:55
When to say no to oncoplastic breast surgery
Ms Emma De Sousa

16:55 to 17:10
Q&A panel discussion with speakers
All Faculty

15:55 to 16:10
BCIR data: 1 year data
Mr Lee Martin

16:10 to 16:25
GIRFT questionnaire data and update
Miss Tracey Irvine

16:25 to 16:40
Multimodal data in clinical practice with LLMs
Professor Pedro Gouveia

16:40 to 16:55
EBCTCG update
Dr David Dodwell, Professor Robert Hills

16:55 to 17:05
Update on the National Breast Cancer Audits
Professor Kieran Horgan

17:05 to 17:10
Q&A Panel Discussion With Speakers
All Faculty

15:55 to 16:10
Myths and misinformation in social media
Dr Cath Biddle

16:10 to 16:25
What we can and can’t do after axillary surgery
Miss Salena Bains

16:25 to 16:45
Myths about radiotherapy
Dr John Conibear

16:45 to 17:00
Myths in genetics and hereditary breast cancer
Professor Diana Eccles

17:00 to 17:10
Q&A panel discussion with speakers
All Faculty

17:15 to 17:20
Completion mastectomy for DCIS and SLNB – ComManDS: An audit of the role of sentinel node biopsy during completion mastectomy for ductal carcinoma in situ
Miss Urvashi Singh

17:20 to 17:25
Lymphoedema rates and severity following TAD vs ALNC
Ms Akriti Nanda

17:25 to 17:30
A population-based study of breast cancer in men in England and Wales
Dr Jemma Boyle

17:30 to 17:35
Comparison of contrast-enhanced mammography and breast MRI in tumour size assessment: A systematic review and meta-analysis
Miss Romy Maas

17:35 to 17:40
The financial impact of using Magseed Localisation versus wire localisation on the Royal Devon and Exeter Breast Department
Dr Charles King

17:40 to 17:45
Chest Wall Perforator Flaps: An observational cohort study of 290 cases to assess surgical, oncological and cosmetic outcomes
Dr Angus Reid

17:45 to 17:50
Variation in rates of immediate breast reconstruction in England and Wales
Dr Liyang Wang

17:50 to 17:55
The risk of contralateral breast cancer during long-term follow-up after breast conserving surgery to inform tailored surveillance protocols
Mr James Lucocq

17:15 to 17:21
Mini symposium sponsored by Merit: iBRA-NET Localisation study: Results of 1000+ SCOUT Radar™ placements
Mr James Harvey

17:21 to 17:28
Mini symposium sponsored by Merit: Non-Magnetic Non-Radioactive Surgery for Breast Conservation in Early Breast Cancer
Mr Vassilis Pitsinis

17:30 to 17:45
Mini symposium sponsored by GC Aesthetics: Broad Application of lipomodellling in Breast Surgery
Miss Rieka Taghizadeh

17:45 to 18:00
Mini symposium sponsored by Novartis: A new paradigm for treating HR+/HER2- early breast cancer patients at high risk of recurrence
Mr Daniel Leff
Tuesday 20 May

08:10 to 08:55
Is the writing on the wall for Tc99? The Case for a Magnetic Future
Ms Anushka Chaudhry, Miss Rachel O'Connell, Dr Eirini Pantiora, Mr Michael Boland

09:00 to 10:15
MDT panel
Dr Anne Armstrong, Mr Ashu Gandhi, Miss Sarah Adomah, Mr Pete Wallroth

09:00 to 09:10
Submitted paper: Preoperative radiotherapy as a risk factor for implant loss - A 9-year retrospective analysis of implant-based reconstructions at the Royal Devon & Exeter Hospital
Ms Giselle Ngan

09:10 to 09:25
SUPREMO
Professor Ian Kunkler

09:25 to 09:40
Radiotherapy: Less is more
Dr John Conibear

09:40 to 09:55
FAST-Forward Boost
Dr Anna Kirby

09:55 to 10:15
Q&A panel discussion with speakers
All Faculty

09:00 to 09:15
Portfolio Pathway in Breast surgery: Tips and tricks for applicants and supervisors
Ms Masooma Zaidi

09:15 to 09:30
The importance of the breast surgeon in the ARCP process
Miss Sisse Olsen

09:30 to 09:45
How I maximise training for my trainees
Ms Sarah Downey

09:45 to 10:00
The Mammary Fold annual survey results and actions
Miss Yasmin Hassen

10:00 to 10:15
Q&A panel discussion with speakers
All Faculty

10:45 to 11:00
When things go wrong with implant-based reconstruction
Miss Rachel Tillett

11:00 to 11:15
Failed implants: What is next?
Dr Nicola Rocco

11:15 to 12:00
Case presentation and panel discussion
Mr Jaroslaw Krupa, Dr Nicola Rocco, Miss Rachel Tillett, Mrs Isabella Karat, Mr Brendan Smith

10:45 to 10:55
Submitted paper: Clinical management and oncological outcomes of pure pleomorphic and florid lobular carcinoma in situ of the breast: Results from the MultiLCIS/OPBC international multicentric study
Dr Massimo Ferrucci

10:55 to 11:25
Wide Local Excision : Are there questions still remaining?
Professor Cliona Kirwan, Professor Kieran Horgan

11:25 to 11:35
B3 Lesions and high risk surveillance: Is 5 years what we need? From a radiology perspective
Dr Nisha Sharma

11:35 to 11:45
B3 Lesions and high-risk surveillance: Is 5 years what we need? From a pathology perspective
Dr Abeer Shaaban

11:45 to 11:55
B3 Lesions and high-risk surveillance: Is 5 years what we need? From a surgical perspective
Professor Lynda Wyld

11:55 to 12:00
Q&A panel discussion with speakers
All Faculty

10:45 to 10:55
Mastitis and Mammary Abscess Management Audit (MAMMA): A survey of patients’ perspective on the management of mammary abscesses in the UK
Ms Alona Courtney

10:55 to 11:05
The efficacy and oncological safety of minimally invasive axillary strategies in node-positive breast cancer in patients receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis
Mr James Lucocq

11:05 to 11:15
Impact of boost radiation for close margins following breast conservation for ductal carcinoma in-situ
Mr Ahmed Ezzat

11:15 to 11:25
Management of infected breast implants; a review with meta-analysis and evidence-based practice recommendation
Dr Sonam Patel

11:25 to 11:35
Confocal Laser Scanning Microscopy (CLSM) for intraoperative histopathological margin assessment in breast conservation surgery
Mr Ken Ho

11:35 to 11:45
Impact of treatment effect on oncological outcomes in patients with a negative sentinel lymph node biopsy after neoadjuvant chemotherapy for initially clinically node-positive disease
Mr Hussain Abdulla

11:45 to 11:55
Patient reported outcome measures in Immediate vs Delayed Contralateral Symmetrisation
Mr Ronak Patel

12:45 to 13:45
Shaping the future of treatment decisions using the Oncotype DX® test: testing before surgery - what can we learn from the PRE-DX study?
Professor Carlo Palmieri, Mrs Caroline Tweedie

13:55 to 14:05
Robotics
Dr Antonio Toesca

14:05 to 14:15
Tripedicle Nipple-Sparing Mastectomy
Dr Nicola Rocco

14:15 to 14:25
Key Considerations in Gender Affirming Mastectomy
Miss Chloe Wright

14:25 to 14:32
Video abstract: Skin-sparing mastectomy with dermal sling, implant and 3D ADM pre-pectoral reconstruction
Miss Sabrina Bezzaa

14:32 to 14:40
Video abstract: Extended ultrasound guided breast conserving surgery associated with LICAP flap mammaplasty
Dr Massimo Ferrucci

14:40 to 14:47
Video abstract: Therapeutic mammoplasty for all 9 zones of the breast - a simplified approach
Mr John Mathew

14:47 to 14:55
Video abstract: How to safely perform augmentation mastopexy
Mr James Lucocq

13:55 to 14:05
Genomic profiling and position of risk algorithms in early breast cancer
Professor Mark Beresford, Dr Catherine Harper-Wynne

14:05 to 14:20
What we know and what we don’t about PREDICT 3
Dr Jeremy Braybrooke

14:20 to 14:45
National Genomics Test Directory update: What is available now and in the near future
Professor Ellen Copson

14:45 to 15:10
Q&A panel discussion with speakers
All Faculty

13:55 to 14:05
An Advanced Clinical Practitioner (ACP) led community primary endocrine therapy (PET) service - A review of 6-years’ progress
Mrs Jacqueline Bailey

14:05 to 14:15
Breast endocrine side-effect clinic at Chesterfield Royal Hospital NHS Foundation Trust 1 year review
Mrs Laura Baggaley

14:15 to 14:25
Pilot program within NHS of R208 seven-gene germline genetic testing in unselected cases of breast cancer delivered using clinician-light pathway: Interim service evaluation findings from first 1756 patients
Mrs Bethany Torr

14:25 to 14:35
Metabolic syndrome - A new prognostic factor in postmenopausal women with oestrogen receptor positive breast cancer: A retrospective cohort study
Miss Rania Diab

14:35 to 14:45
Survival after breast-conserving surgery in patients with multi-site breast cancer
Miss Rebecca Swan

14:45 to 14:55
A system-wide approach to enable equitable access to risk-reducing endocrine therapy: Part of the Greater Manchester Endocrine Therapy Improvement Programme (ETIP)
Miss Clare Garnsey

14:55 to 15:05
The impact of patient and clinical characteristics on the experience of care for breast cancer patients in England: An analysis of Cancer Patient Experience Survey data
Miss Sarah Blacker

15:10 to 15:20
Best way to perform a total en-bloc capsulectomy for confirmed or suspected breast implant-associated anaplastic large cell lymphoma
Miss Emma Blower

15:20 to 15:30
Can the nipple be saved? The role of surgical nipple delay
Ms Rebecca Stoner

15:30 to 15:40
A simple technique to reduce T-junction tension during wise pattern mammoplasties
Mr Hud Shaker

15:40 to 15:50
Non-clinical triaging
Mrs Kathryn Ellis

15:50 to 16:00
Getting back to normal activities information sheet and Breast Oedema advice leaflet
Mrs Lorraine Walker

16:00 to 16:25
Q&A panel with discussion with all speakers
All Faculty

15:10 to 15:35
Debate: Patients with >3 abnormal nodes on axillary ultrasound at presentation should not be considered for sentinel node biopsy after neoadjuvant chemotherapy
Professor Aoife Lowery, Professor Stuart McIntosh

15:35 to 16:00
Debate: Targeted Axillary Surgery (SLNB and excision of abnormal node) should be considered in all post-menopausal patients with one abnormal node on axillary ultrasound
Mr Daniel Leff, Ms Ruth Prichard

16:00 to 16:25
Debate: Patients undergoing risk reducing mastectomy should be offered a robotic approach where possible
Professor Arnold Hill, Dr Andreas Karakatsanis